These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25631543)

  • 1. Blood pressure and hypertension in athletes: a systematic review.
    Berge HM; Isern CB; Berge E
    Br J Sports Med; 2015 Jun; 49(11):716-23. PubMed ID: 25631543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure and left ventricular hypertrophy during American-style football participation.
    Weiner RB; Wang F; Isaacs SK; Malhotra R; Berkstresser B; Kim JH; Hutter AM; Picard MH; Wang TJ; Baggish AL
    Circulation; 2013 Jul; 128(5):524-31. PubMed ID: 23897848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial myocardial function in either physiological or pathological left ventricular hypertrophy: a two-dimensional speckle strain study.
    D'Andrea A; De Corato G; Scarafile R; Romano S; Reigler L; Mita C; Allocca F; Limongelli G; Gigantino G; Liccardo B; Cuomo S; Tagliamonte G; Caso P; Calbrò R
    Br J Sports Med; 2008 Aug; 42(8):696-702. PubMed ID: 18070810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiographic deformation imaging reveals preserved regional systolic function in endurance athletes with left ventricular hypertrophy.
    Teske AJ; Prakken NH; De Boeck BW; Velthuis BK; Doevendans PA; Cramer MJ
    Br J Sports Med; 2010 Sep; 44(12):872-8. PubMed ID: 19136502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise-induced cardiac remodeling in non-elite endurance athletes: Comparison of 2-tiered and 4-tiered classification of left ventricular hypertrophy.
    Trachsel LD; Ryffel CP; De Marchi S; Seiler C; Brugger N; Eser P; Wilhelm M
    PLoS One; 2018; 13(2):e0193203. PubMed ID: 29462182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortic stiffness and distensibility in top-level athletes.
    D'Andrea A; Cocchia R; Riegler L; Salerno G; Scarafile R; Citro R; Vriz O; Limongelli G; Di Salvo G; Caso P; Bossone E; Calabrò R; Russo MG
    J Am Soc Echocardiogr; 2012 May; 25(5):561-7. PubMed ID: 22245050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positron emission tomographic evaluation of regulation of myocardial perfusion in physiological (elite athletes) and pathological (systemic hypertension) left ventricular hypertrophy.
    Kjaer A; Meyer C; Wachtell K; Olsen MH; Ibsen H; Opie L; Holm S; Hesse B
    Am J Cardiol; 2005 Dec; 96(12):1692-8. PubMed ID: 16360359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular hypertrophy in middle-aged endurance athletes: is it blood pressure related?
    Małek ŁA; Czajkowska A; Mróz A; Witek K; Barczuk-Falęcka M; Nowicki D; Postuła M; Werys K
    Blood Press Monit; 2019 Jun; 24(3):110-113. PubMed ID: 30969227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild Left Ventricular Hypertrophy in Middle-Age Male Athletes as a Sign of Masked Arterial Hypertension.
    Małek ŁA; Jankowska A; Greszata L
    Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood pressure response to maximal dynamic exercise testing in an athletic population.
    Pressler A; Jähnig A; Halle M; Haller B
    J Hypertens; 2018 Sep; 36(9):1803-1809. PubMed ID: 29794559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of blood pressure control on prevalence of left ventricular hypertrophy in treated hypertensive patients.
    Cuspidi C; Lonati L; Sampieri L; Macca G; Michev I; Salerno M; Fusi V; Leonetti G; Zanchetti A
    Cardiology; 2000; 93(3):149-54. PubMed ID: 10965085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial.
    Soliman EZ; Byington RP; Bigger JT; Evans G; Okin PM; Goff DC; Chen H
    Hypertension; 2015 Dec; 66(6):1123-9. PubMed ID: 26459421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of Blood Pressure Measurement Technique for Implementation of Systolic Blood Pressure Intervention Trial (SPRINT).
    Agarwal R
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of resting cardiovascular dysfunction in middle-aged endurance-trained athletes with exaggerated exercise blood pressure responses.
    Currie KD; Sless RT; Notarius CF; Thomas SG; Goodman JM
    J Hypertens; 2017 Aug; 35(8):1586-1593. PubMed ID: 28350576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
    Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
    G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of blood pressure to predict left ventricular hypertrophy in children with primary hypertension.
    Brady TM; Fivush B; Flynn JT; Parekh R
    J Pediatr; 2008 Jan; 152(1):73-8, 78.e1. PubMed ID: 18154904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can pathological left ventricular hypertrophy in arterial hypertension be distinguished from physiological hypertrophy caused by sports?].
    Schannwell CM; Marx R; Plehn G; Perings C; Leschke M; Strauer BE
    Dtsch Med Wochenschr; 2001 Mar; 126(10):263-7. PubMed ID: 11285760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure variability in controlled and uncontrolled blood pressure and its association with left ventricular hypertrophy and diastolic function.
    Wittke EI; Fuchs SC; Moreira LB; Foppa M; Fuchs FD; Gus M
    J Hum Hypertens; 2016 Aug; 30(8):483-7. PubMed ID: 26467817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized study of traditional versus aggressive systolic blood pressure control (Cardio-Sis): rationale, design and characteristics of the study population.
    Cardio-Sis Study Group
    J Hum Hypertens; 2008 Apr; 22(4):243-51. PubMed ID: 18046432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: influence of blood pressure and humoral and neurohormonal factors.
    Martinez-Vea A; Valero FA; Bardaji A; Gutierrez C; Broch M; Garcia C; Richart C; Oliver JA
    Am J Nephrol; 2000; 20(3):193-200. PubMed ID: 10878400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.